drugset
drugset / Trial / NCT05148689

A Study Comparing Oxymetazoline 1% Cream to RHOFADE

NCT05148689 ↗

Phase 1 Completed 82 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

randomized, double-blind, placebo controlled

Timeline

Start
2018-02-23
Primary completion
2019-03-21
Completion
2019-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxymetazoline Other / unclassified 1 % —

Indications

No indication recorded.